Clinical Trials Browser

Withdrawn × Leukapheresis × Breast × Clear all

NCT05539365 2025-01-29

Dendritic Cell-Based Treatment Plus Immunotherapy for the Treatment of Metastatic or Unresectable Triple Negative Breast Cancer

Phase 2 Withdrawn

Triple Negative Breast Neoplasms